Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
10/2008
10/16/2008US20080255162 Treating diseases mediated by phosphatidyl inositol 3-kinase; cardiovascular disorders; anticarcinogenic, antiarthritic, anticoagulant, antiinflammatory, antiischemic,and hypotensive agents; chronic obstructive pulmonary disease; autoimmune diseases; diabetes, atherosclerosis, bronchitis, strokes
10/16/2008US20080255161 3-HYDROQUINAZOLIN-4-ONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS
10/16/2008US20080255154 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: N-methyl-5-[4-(1-{[3-oxo-1'H,3H-spiro[2-benzofuran-1,3'-pyrrolidin]-1'-yl]carbonyl}cyclopropyl)phenyl]pyridine-2-carboxamide; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; diabetes
10/16/2008US20080255145 Thiadiazole compounds and methods of use
10/16/2008US20080255144 (3'-Chloro-4-methanesulfonyl-biphenyl-2-yl)-[4-(3,4-dichloro-phenyl)-piperazin-1-yl]-methanone; neurological and neuropsychiatric disorders including schizophrenia
10/16/2008US20080255143 Inhibitors of Akt Activity
10/16/2008US20080255142 Substituted Piperidine Derivatives as Somatostatin Sst1 Receptor Antagonists
10/16/2008US20080255133 N-(2-aylamino)aryl sulfonamides such as N-(7-(4-bromo-2-fluorophenylamino)imidazo[1,2-b]pyridazin-6-yl)-1-(2-hydroxyethyl)cyclopropane-1-sulfonamide; mitogen-activated ERK activating kinase (MEK) inhibitors; antiproliferative, anticarcinogenic, and antiinflammatory agents
10/16/2008US20080255130 Bicyclic Nitrogen-containing Heterocyclic compounds for use as Stearoyl CoA Desaturase inhibitors
10/16/2008US20080255119 e.g. 5-[rac-cis-2,3-Bis-(4-chloro-phenyl)-5-oxo-2,3-dihydro-5H-imidazo[1,2-a]pyridine-1-sulfonyl]-2-fluoro-benzonitrile; inhibit the interaction of tumor suppressor MDM2 protein with a p53-like peptide; antiproliferative agent; cycle arrest in G1 and G2 phase
10/16/2008US20080255110 Imidazoquinoline derivatives as adenosine a3 receptor ligands
10/16/2008US20080255106 N-(3-Methoxypropyl)-2-[2-(trifluoromethyl)phenyl]-3H-imidazo[4,5-b]pyridine-7-carboxamide hydrochloride; antidepressant, analgesic, anxiolytic agent; amyotrophic lateral sclerosis, Down syndrome, Huntington's Disease, bipolar disease, affective disorders, depression, schizophrenia, cognitive disorder
10/16/2008CA2683598A1 1,3,8-trisubstituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives as ligands of the orl-i receptor for the treatment of anxiety and depression
10/16/2008CA2683453A1 Substituted 2,3,4,5-tetrahydro-1h-pyrido[4,3-.beta.]indoles, methods for the production and use thereof
10/16/2008CA2683398A1 Fused ring heterocycle kinase modulators
10/16/2008CA2683046A1 Non-nucleoside reverse transcriptase inhibitors
10/16/2008CA2682981A1 Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors
10/16/2008CA2682925A1 Heteroaryl amide analogues
10/16/2008CA2682875A1 Imidazolidine carboxamide derivatives as lipase and phospholipase inhibitors
10/16/2008CA2682340A1 [2 , 6] naphthyridines useful as protein kinase inhibitors
10/16/2008CA2682339A1 2 , 6-naphthyridine derivatives as protein kinase modulators
10/16/2008CA2682287A1 1-(1-benzylpiperidin-4-yl)benzimidaz0le -5-carboxylic acid derivatives for the treatment of diabetes mellitus
10/16/2008CA2681163A1 Heterocycles as orexin antagonists
10/15/2008EP1980561A1 Substituted 1h-pyrazolo[3,4-b] pyridine derivatives active as kinase inhibitors
10/15/2008EP1979355A1 Spiro imidazole derivatives as ppar modulators
10/15/2008EP1979354A1 Diaza-spiro-[4, 5]-decanes useful as pesticides
10/15/2008EP1979353A2 Fused heterobicyclic kinase inhibitors
10/15/2008EP1979352A2 Pyridopyrimidone derivatives, preparation thereof, therapeutic use thereof
10/15/2008EP1979351A1 6-phenyl-1h-imidazo[4, 5-c]pyridine-4-carbonitrile derivatives as cathepsin k and s inhibitors
10/15/2008EP1979350A1 Aryl-isoxazol-4-yl-imidazo[1,2-a]pyridine useful for the treatment of alzheimer's disease via gaba receptors
10/15/2008EP1979349A2 Anti-viral compounds
10/15/2008EP1979348A2 Anti-viral compounds
10/15/2008EP1979343A2 Bicyclic heteroaryl compounds as pde10 inhibitors
10/15/2008EP1979342A1 Compounds for the inhibition of integrins and use thereof
10/15/2008EP1979323A1 Process for the stereoselective preparation of alcohols from alpha, beta-insaturated compounds
10/15/2008EP1978967A1 Quinazolinone derivatives as vanilloid antagonists
10/15/2008EP1904492B1 Method for obtaining the pharmaceutically active compound dolasetron, synthesis intermediates thereof and methods for obtaining them
10/15/2008EP1742642B1 Phosphonate analogs of hiv integrase inhibitor compounds
10/15/2008EP1660085B1 Pyridylpyrrole derivatives active as kinase inhibitors
10/15/2008EP1567520B1 Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents
10/15/2008EP1567112B1 THIAZOLIDIN-4-ONES FOR INHIBITING hYAK3 PROTEINS
10/15/2008EP1544199B1 Nitrogenous condensed-ring compound and use thereof as hiv integrase inhibitor
10/15/2008EP1458723B1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
10/15/2008EP1411940B1 Bridged piperidine derivatives as melanocortin receptor agonists
10/15/2008EP1375486B1 Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity
10/15/2008EP1308439B1 Proline derivatives and use thereof as drugs
10/15/2008CN101287735A Inhibitors of the HIV integrase enzyme
10/15/2008CN101287734A 2-氨基-7,8-二氢-6H-吡啶并[4,3-d]嘧啶-5-酮 2-amino-7,8-dihydro--6H- pyrido [4,3-d] pyrimidin-5-one
10/15/2008CN101287733A Novel isoindole derivatives, compositions containing same, preparation thereof and pharmaceutical uses thereof in particular as inhibitors of chaperone protein Hsp90 activities
10/15/2008CN101287726A Pyrrolidine and piperidine acetylene derivatives for use as MGLUR5 antagonists
10/15/2008CN101287725A DNA-PK inhibitors
10/15/2008CN101287707A 激酶抑制剂 Kinase inhibitors
10/15/2008CN101284819A Fused pyridazine derivative compounds and drugs containing these compounds as the active ingredient
10/14/2008US7436570 Electrochromic salts, solutions, and devices
10/14/2008US7435829 Pyrazolyl-substituted heterocycles and their use as phytosanitary products
10/14/2008US7435823 2,3-Dihydro-4H-1,4-benzoxazine derivatives containing an optionally fused pyridine or pyrimidine ring; 7-((6,7-bis(methyloxy)-4-quinolinyl)oxy)-N-phenyl-2,3-dihydro-4H-1,4-benzoxazine-4-carboxamide; kinase inhibitors; inflammation, angiogenesis and cancer
10/14/2008US7435820 Substituted tetrahydro-1H-pyrazolo [3,4-c]pyridines compositions comprising them, and use
10/14/2008US7435819 4,5,6,7-tetrahydro-[1,2]dithiolo[4,3-C] pyridine-3-thione compounds
10/14/2008US7435750 Method of using substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof
10/14/2008US7435743 I kappa B kinase beta inhibitors that are 2-amino-4,6-disubstituted nicotinic acid ester analogs; antiinflammatory, antitumor and antiischemic effects; asthma; nuclear factor kappa B inhibitors; 7-(2-hydroxyphenyl)-5-(3-piperidinyl)-1,4-dihydro-2H-pyrido[2,3-d][1,3]oxazin-2-one
10/14/2008US7435740 e.g. 1-Benzyl-7-phenyl-3-propyl-1H-pyrrolo[1,2-f]purine-2,4(3H,6H)-dione; antiinflammatory, anticarcinogenic agent; cerebral ischemia, asthma, neurodegeneration, glaucoma, ischemic heart pre-conditioning; diagnostic agents
10/14/2008US7435735 Hydroxy pyridopyrrolopyrazine dione compounds useful as HIV integrase inhibitors
10/14/2008US7435731 Substituted pyrazolo[3,4-d]pyrimadines and methods of using the same
10/14/2008US7435728 Pyrazole derivatives
10/14/2008CA2382880C N-cyclopentyl modulators of chemokine receptor activity
10/14/2008CA2275351C Novel counterparts of camptothecin, their application as medicine and pharmaceutical compositions containing them
10/09/2008WO2008121860A1 Peripheral opioid receptor antagonists and uses thereof
10/09/2008WO2008121687A2 Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors
10/09/2008WO2008121333A1 Certain chemical entities, compositions and methods
10/09/2008WO2008121064A1 New imidazo[4,5-b]pyridine-6-halo-7-aryl/heteroaryl compounds 705
10/09/2008WO2008121063A1 New imidazo[ 4,5-b]pyridine-7-carboxamides 704
10/09/2008WO2008120806A1 Novel condensed ring aromatic compound and organic light-emitting device having the same
10/09/2008WO2008120235A1 Novel benzophenone hybrids as potential anticancer agents and a process for the preparation thereof
10/09/2008WO2008120000A1 Therapeutic agents
10/09/2008WO2008119999A1 Therapeutic agents
10/09/2008WO2008119713A1 1- (1-cyclohexyl-4-piperidinyl) -1, 3-dihydro-2h-benzimidazol-2-one derivatives which have activity on the m1 receptor and their use in medicine
10/09/2008WO2008100622A3 Biaryl-substituted tetrahydro-pyrazolo-pyridine modulators of cathepsin s
10/09/2008WO2008079521A3 Tricyclic heteroaryl compounds useful as inhibitors of janus kinase
10/09/2008WO2008022002A3 2-amido-4-isoxazolyl thiazole compounds exhibiting atp-utilizing enzyme inhibitory activity, and compositions, and uses thereof
10/09/2008US20080249310 Process For the Preparation of (2R,3R)-2-Hydroxy-3-Amino-3-Aryl-Propionamide and (2R,3R)-2-Hydroxy-3-Amino-3-Aryl-Propionic Acid Alkyl Ester
10/09/2008US20080249309 N,N-disubstituted perylene-3,4:9,10-bis(dicarboximides), used as n-type junctions, integrated in various device designs including, circuits, thin film transistors, light-emitting diodes, photoelectric cells, detectors and capacitors
10/09/2008US20080249126 1,3-substituted cycloalkyl derivatives having acidic, mostly heterocyclic groups, processes for their preparation and their use as pharmaceuticals
10/09/2008US20080249125 N-methyl-2-phenyl-2-{7-[2-(4-trifluoromethyl-phenyl)-ethyl]-4,7-dihydro-5H-thieno[2,3-c]pyridin-6-yl}-acetamide; sleep disorders
10/09/2008US20080249122 1,3,8-trisubstituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives as ligands of the orl-1 receptor
10/09/2008US20080249112 Antiproliferavtive agents; small molecule inhibitors of KSP(kinesin-related proteins); N-(3-aminopropyl)-N-[1-(3-benzyl-4-oxo-6,7,8 ,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-2-yl)propyl]-4-bromobenzamide
10/09/2008US20080249105 And Erectile Dysfunction; rho kinase inhibitors; [3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]amine
10/09/2008US20080249101 BENZOIMIDAZOLE, TETRAHYDRO-QUINOXALINE, BENZOTRIAZOLE, DIHYDRO-IMIDAZO[4,5-c] PYRIDINONE AND DIHYDRO-ISOINDOLONE DERIVATIVES
10/09/2008US20080249090 1-(4-(1H-pyrrol-1-yl)phenyl)-3-(2-aminoquinazolin-6-yl)-4-methylpyridin-2(1H)-one; modulators of kinase enzymes such as c-kit, and useful for the regulation of autoimmune disease(s), allergies, asthma, cancer and the like
10/09/2008US20080249071 inhibitory activity against the activation of inflammatory cytokines such as interleukin (IL)-1, IL-6, IL-8 and tumor necrosis factor (TNF- alpha ), NF- kappa K B; inflammatory disorders, autoimmune diseases; side effects reduction; immuno suressants; N-[3,5-bis(trifluoromethyl)phenyl]-2-hydroxybenzamide
10/09/2008US20080248134 antiproliferative agents for inducing p53 expression and decreasing survivin expression in cells; multidrug resistant proliferative disorders; synergistic use with other chemotherapeutic agents like temozolomide
10/09/2008US20080247964 Substituted azaspiro derivatives
10/09/2008CA2682715A1 New imidazo[4,5-b]pyridine-7-carboxamides 704
10/09/2008CA2682550A1 Peripheral opioid receptor antagonists and uses thereof
10/09/2008CA2682384A1 Benzophenone hybrids as potential anticancer agents and a process for the preparation thereof
10/09/2008CA2682231A1 Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors
10/08/2008EP1976849A2 Compounds for the treatment of inflammatory disorders
10/08/2008EP1976848A2 Phenoxypiperidines and analogs thereof useful as histamine h3 antagonists
10/08/2008EP1976837A1 Dicarbonylic compounds with antibacterial activity
10/08/2008EP1976836A2 Nitrogen-containing bicyclic heteroaryl compounds for the treatment of raf protein kinase-mediated diseases
10/08/2008EP1976527A2 Fused triazole tachykinin receptor antagonists